Ensemble said April 5 that the milestone happened exactly one year after the implant was introduced to the market.
“Our early experience suggests the implant presents an attractive choice for surgeons to offer patients and is becoming an accepted treatment alternative,” Ensemble CEO and co-founder William Ogilvie said. “We are extremely pleased with the progress of our controlled market rollout and very happy that our select group of trained surgeons are integrating the Ensemble [carpometacarpal implant] into their practices.”
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.